Goodman Marc T, Shvetsov Yurii B, McDuffie Katharine, Wilkens Lynne R, Zhu Xuemei, Thompson Pamela J, Ning Lily, Killeen Jeffrey, Kamemoto Lori, Hernandez Brenda Y
Epidemiology Program, Cancer Research Center of Hawaii and University Health Services, University of Hawaii, Honolulu, Hawaii 96813, USA.
Cancer Res. 2008 Nov 1;68(21):8813-24. doi: 10.1158/0008-5472.CAN-08-1380.
Few natural history studies of cervical human papillomavirus (HPV) incidence and duration have been conducted among older women, especially from multiethnic populations. Viral and nonviral determinants of HPV acquisition and clearance were examined among 972 sexually active women, ages 18 to 85 years, recruited from clinics on Oahu, Hawaii, and followed for a mean duration of 15 months (range, 2-56 months). Interviews and cervical cell specimens for cytology and HPV DNA detection by PCR, using the PGMY09/PGMY11 primer system, were obtained at baseline and at 4-month intervals. The prevalence of cervical HPV infection was 25.6% at study entry. A total of 476 incident genotype-specific infections were observed during the follow-up period. The incidence of high-risk (HR) HPV types (9.26 per 1,000 woman-months) was similar to low-risk (LR) HPV types (8.24 per 1,000 woman-months). The most commonly acquired HR-HPV types were HPV-52, HPV-16, and HPV-31; and their incidence was increased significantly with a coexisting cervical HPV infection. Cervical HPV acquisition decreased with age, income, and long-term use of oral contraceptives and increased with number of sexual partners, use of hormonal creams, alcohol drinking, and condom use by a sexual partner. Cohort participants cleared 265 of the 476 incident infections during follow-up. LR-HPV infections cleared more rapidly than did HR-HPV infections (median, 180 days versus 224 days). Clearance times were enhanced among older women and women with multiple infections. Our data suggest several viral and nonviral determinants of cervical HPV acquisition and clearance that might be used in cervical cancer prevention programs.
针对老年女性,尤其是多民族人群中的宫颈人乳头瘤病毒(HPV)发病率和持续时间的自然史研究较少。在972名年龄在18至85岁的性活跃女性中,研究了HPV感染和清除的病毒及非病毒决定因素,这些女性是从夏威夷瓦胡岛的诊所招募的,平均随访时间为15个月(范围为2至56个月)。在基线和每隔4个月时进行访谈,并采集宫颈细胞样本用于细胞学检查以及使用PGMY09/PGMY11引物系统通过PCR检测HPV DNA。研究开始时宫颈HPV感染的患病率为25.6%。在随访期间共观察到476例基因型特异性感染病例。高危(HR)HPV类型的发病率(每1000女性 - 月9.26例)与低危(LR)HPV类型(每1000女性 - 月8.24例)相似。最常见的获得性HR - HPV类型为HPV - 52、HPV - 16和HPV - 31;并且在同时存在宫颈HPV感染时其发病率显著增加。宫颈HPV感染率随年龄、收入和长期口服避孕药的使用而降低,随性伴侣数量、激素乳膏的使用、饮酒以及性伴侣使用避孕套而增加。队列参与者在随访期间清除了476例感染病例中的265例。LR - HPV感染比HR - HPV感染清除得更快(中位数分别为180天和224天)。老年女性和多重感染女性的清除时间更长。我们的数据表明了几种可能用于宫颈癌预防计划的宫颈HPV感染和清除的病毒及非病毒决定因素。